Clinical Trial Update: Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial is evaluating trifluridine/tipiracil in combination with capecitabine and bevacizumab for metastatic colorectal cancer; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Lonsurf (trifluridine/tipiracil)
• Xeloda (capecitabine)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING